Novo Nordisk
$46.81
20321
+$0.48+1.04% Friday 19:45
Statistics
Day High
47
Day Low
46.7
52W High
64.75
52W Low
34
Volume
3,200
Avg. Volume
41,622
Mkt Cap
205.08B
P/E Ratio
11.59
Dividend Yield
3.87%
Dividend
1.81
Upcoming
Dividends
3.87%Dividend Yield
Aug 26
$0.58
Mar 26
$1.23
Aug 25
$0.58
Apr 25
$1.14
Aug 24
$0.52
10Y Growth
7%
5Y Growth
19.72%
3Y Growth
20.72%
1Y Growth
4.83%
Earnings
4NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
0.71
0.81
0.92
1.02
Expected EPS
0.7725808842
Actual EPS
N/A
Financials
33.06%Profit Margin
Profitable47.69BRevenue
15.77BNet Income
Analyst Ratings
41.00Average Price Target
The highest estimate is 41.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy 0%
Hold 100%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow NONOF. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Sanofi
SNY
Mkt Cap104.76B
Lilly(Eli) &
LLY
Mkt Cap1.05T
Astrazeneca
AZN
Mkt Cap242.64B
Merck
MRK
Mkt Cap335.14B
Bristol-Myers Squibb
BMY
Mkt Cap130.39B
Pfizer
PFE
Mkt Cap152.69B
Novartis
NVS
Mkt Cap286.78B
Johnson & Johnson
JNJ
Mkt Cap627.42B
Abbott Laboratories
ABT
Mkt Cap192.51B
Thermo Fisher Scientific
TMO
Mkt Cap217.52B
About
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Show more...
CEO
Maziar Mike Doustdar
Employees
69500
Country
Denmark
ISIN
DK0062498333
WKN
000A3EU6F
Listings
0 Comments
Share your thoughts
FAQ
What is Novo Nordisk stock price today?▼
The current price of NONOF is $46.81 USD — it has increased by +1.04% in the past 24 hours. Watch Novo Nordisk stock price performance more closely on the chart.
What is Novo Nordisk stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Novo Nordisk stocks are traded under the ticker NONOF.
Is Novo Nordisk stock price growing?▼
NONOF stock has risen by +3.7% compared to the previous week, the month change is a -3.46% fall, over the last year Novo Nordisk has showed a -18.02% decrease.
What is Novo Nordisk market cap?▼
Today Novo Nordisk has the market capitalization of 205.08B
When is the next Novo Nordisk earnings date?▼
Novo Nordisk is going to release the next earnings report on November 04, 2026.
What were Novo Nordisk earnings last quarter?▼
NONOF earnings for the last quarter are 0.94 USD per share, whereas the estimation was 0.77 USD resulting in a +22.85% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Novo Nordisk revenue for the last year?▼
Novo Nordisk revenue for the last year amounts to 47.69B USD.
What is Novo Nordisk net income for the last year?▼
NONOF net income for the last year is 15.77B USD.
Does Novo Nordisk pay dividends?▼
Yes, NONOF dividends are paid semi-annual. The last dividend per share was 0.58 USD. As of today, Dividend Yield (FWD)% is 3.87%.
How many employees does Novo Nordisk have?▼
As of August 22, 2026, the company has 69,500 employees.
In which sector is Novo Nordisk located?▼
Novo Nordisk operates in the Health & Wellness sector.
When did Novo Nordisk complete a stock split?▼
The last stock split for Novo Nordisk was on September 13, 2023 with a ratio of 2:1.
Where is Novo Nordisk headquartered?▼
Novo Nordisk is headquartered in Bagsvaerd, Denmark.